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ABSTRACT
Objectives: The aim of our study is to determine whether first-trimester neutrophil-to-lymphocyte ratio (NLR) and plate-
let-to-lymphocyte ratio (PLR) would be useful as new predictors of subsequent preeclampsia. 
Material and methods: Medical records of women with preeclampsia and healthy controls from a tertiary referral center 
were retrospectively evaluated. The two groups were compared in terms of clinical characteristics and first-trimester levels 
of hemoglobin, leukocyte, neutrophil, lymphocyte, platelet, NLR and PLR. Receiver operating characteristic curve (ROC) 
analysis was performed to identify the optimal NLR and PLR levels predicting preeclampsia. 
Results: Neutrophil (p < 0.001), platelet (p < 0.001), NLR (p < 0.001) and PLR (p < 0.001) levels were significantly elevated, 
whereas hemoglobin concentration (p = 0.003) was significantly lower in the group with preeclampsia as compared to 
the control group. On multivariate regression analysis, NLR (OR 1.43; 95% CI 1.21–1.76; p = 0.005) and PLR (OR 1.38; 95% 
CI 1.15–1.63; p = 0.008) were the most powerful predictive variables. The area under the ROC was 0.716 and 0.705 for NLR 
and PLR, respectively. The cut-off values of NLR ≥ 3.08 and PLR ≥ 126.8 predicted preeclampsia with the sensitivity of 74.6% 
and 71.8% and specificity of 70.1% and 72.4%, respectively. 
Conclusions: High NLR and PLR during the first trimester are independent predictors of subsequent preeclampsia.
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INTRODUCTION
Preeclampsia is characterized by a new onset of hyper-
tension and proteinuria after 20 weeks of gestation in a pre-
viously normotensive pregnant woman [1]. It is one of the 
most common complications of pregnancy, affecting 3–5% 
of all pregnant women and is responsible for 12% of the 
global maternal mortality [1]. Numerous etiological factors 
have been proposed to explain the pathological changes in 
preeclampsia. According to previous publications, deficient 
trophoblastic invasion in the first trimester results in preec-
lampsia later in pregnancy. The altered immune response of 
a gravid woman, causing excessive maternal inflammation 
and poor placentation, leading to increased capillary perme-
ability, micro-vascular thrombosis, and increased vascular 
tone, has been among the proposed mechanisms [2, 3].
Recently, elevated neutrophil-to-lymphocyte ratio 
(NLR) and platelet-to-lymphocyte ratio (PLR) have gener-
ated significant interest as systemic inflammatory response 
markers in various clinical circumstances. Elevated NLR is 
associated with increased cardiovascular risk and mor-
tality in some malignancies [4]. PLR is assumed to show 
increased platelet activation which leads to initiation and 
progression of atherosclerosis [4]. However, the predictive 
value of NLR and PLR in the early diagnosis of preeclampsia 
remains unclear. 
Therefore, the aim of our study was to assess the di-
agnostic value of NLR and PLR, as well as neutrophil, lym-
phocyte and platelet counts during the first trimester of 
gestation to predict the subsequent development of preec-
lampsia.
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MATERIAL AND METHODS
Our retrospective study included 209 pregnant women 
diagnosed with preeclampsia and 221 normotensive preg-
nant controls, presenting at the Department of Perinatology 
between January 2013 and April 2015. Local Ethics Commit-
tee approved of the study. The diagnosis of preeclampsia 
was made in accordance with the American College of Ob-
stetrics and Gynecology criteria [5]. All preeclamptic patients 
were diagnosed between 22 to 40 weeks of gestation. The 
control group consisted of pregnant women who gave birth 
to children between 38 to 41 weeks, appropriate for gesta-
tional age, without any history of complications throughout 
the pregnancy. First-trimester (7–14 weeks) complete blood 
cell counts (CBC) were obtained in all patients. Patients with 
systemic diseases, history of hematopoietic system disor-
ders, malignancies, acute or chronic inflammatory diseases, 
and those who were on any medication which could have 
affected the CBC results were excluded from the study. 
The following clinical data were collected from patient 
medical reports: maternal age, parity, abortus, body mass 
index, type of conception, smoking habit, gestational age at 
the time of diagnosis, fetal gender, gestational age at deliv-
ery, type of delivery, gender, birth weight and percentile of 
the newborn and first-trimester CBC. CBC was performed in 
the first trimester at our center using a Coulter LH 750 device 
(Beckman Coulter, Brea, CA, USA). When more than one CBC 
result was available, the result of the date which is closest to 
7 weeks of gestation was recorded for statistical analysis. NLR 
was defined as the absolute neutrophil count divided by 
the absolute lymphocyte count, and PLR was defined as the 
absolute platelet count divided by the lymphocyte count. 
Percentile of the fetal weight was calculated by the Hadlock 
formula and fetal weight < 5 percentile was accepted as 
small for gestational age [6].
The study group was assessed for the presence of 
preeclampsia and their first-trimester inflammation mark-
ers. Statistical analyses were performed using SPSS (SPSS 
for Windows version 20.0, Chicago, Illinois, USA). Chi-square 
analysis was used to analyze categorical variables, Student’s 
t-test was used for normally distributed variables and the 
Mann-Whitney U-test was used for non-normally distrib-
uted variables. Relative risks with 95% confidence intervals 
(CIs) were calculated. A p-value of < 0.05 was considered as 
statistically significant. A receiver operating characteristic 
(ROC) curve was used to evaluate the cut-off, sensitivity, 
and specificity values.
RESULTS
Clinical characteristics of the preeclamptic and control 
groups are presented in Table 1. Gestational age at delivery 
(p < 0.001), birthweight (p < 0.001), and birth percentile 
(p < 0.001) were significantly lower and the cesarean section 
rate (p < 0.001) was significantly higher in the preeclamptic 
group as compared to healthy controls. Among serum mark-
ers, hemoglobin levels (p = 0.003) were significantly lower 
and the values of neutrophil (p < 0.001), platelet (p < 0.001), 
NLR (p < 0.001), and PLR (p < 0.001) were significantly higher 
in the group with preeclampsia as compared to the control 
group.
In multivariate analysis, NLR and PLR remained the most 
powerful predictors (p = 0.005 and p = 0.008, respectively) 
(Table 2). ROC curve analysis suggested that NLR (area un-
der the curve [AUC] = 0.716; 95% CI 0.666–0.766; p < 0.001) 
and PLR (AUC = 0.705; 95% CI 0.656–0.754; p < 0.001) had 
the highest AUC in predicting preeclampsia (Table 3 and 
Figure 1). The optimum cut-off points for NLR and PLR were 
3.08 (sensitivity: 74.6%, specificity: 74.6%) and 126.8 (sensi-
tivity:71.8%, specificity:72.4%), respectively.
DISCUSSION
Current evidence suggests that a vascular endothelial 
multisystem disorder which leads to microvascular throm-
bosis induced by platelets, increased capillary permeabil-
ity, increased vascular tone and hypertension, contributes 
to the pathogenesis of preeclampsia [3]. Altered immune 
response, excessive maternal inflammation, and immune 
maladaptation are also among the proposed etiological 
factors [2]. Sacks et al., demonstrated a massive influx of 
proinflammatory macrophages and a natural killer in hu-
man decidua in the first trimester as early as 4 weeks of 
gestation [7]. The results of their research prompted us to 
believe that initiation of preeclampsia might be predicted 
by assessing the values of NLR and PLR, which are systemic 
inflammatory markers in the first trimester of pregnancy.
Various studies have shown white blood cell subtypes 
to be associated with cardiovascular diseases. Neutrophils 
are reported to have a role in atherogenesis and athero-
thrombosis [8]. Neutrophils also play an important role in 
the inflammatory processes. They are the first blood cells 
responding to inflammation [4]. Kurt et al., reported higher 
neutrophil counts in preeclamptic patients, implying the 
presence of an increased inflammatory state [9]. Our find-
ings are consistent with their results as we detected the 
mean neutrophil count in the first trimester to be signifi-
cantly higher in the group with preeclampsia. 
Troeger el al., reported that increased erythropoietic 
stimulation associated with placental hypoxia can be detect-
ed in preeclamptic patients [10]. This tissue hypoxia causes 
secretion of erythropoietin and stimulates bone marrow, 
resulting in increased megakaryocyte and platelet counts 
[11]. Activated platelets and neutrophils pass through the 
intervillous space and cause endothelial dysfunction [1]. It 
was hypothesized that activation of platelets during tropho-
blast invasion in early pregnancy can differ between in 
433
Cenk Gezer et al., Predictors of preeclampsia
www. journals.viamedica.pl/ginekologia_polska
preeclamptic and healthy individuals [2]. Altered platelet 
reactivity was detected in preeclampsia and suggested as 
an early marker for the disease [12]. Similar to our study, 
Tzur et al., reported high first-trimester platelet counts in 
preeclamptic patients [13]. 
High NLR and PLR have been found to be associated 
with increased inflammation. These markers were studied 
as new predictors for various illnesses. Higher platelet count 
is also associated with adverse cardiovascular outcomes in 
cardiac diseases, and high PLR value is used as a marker 
for long term mortality [14]. The results of our study on 
preeclampsia are in agreement with other studies, sug-
Table 1. Clinical characteristics of the study group
Parameters Preeclampsia group(n = 209)
Normotensive group
(n = 221) P value
Maternal age (years)† 26.6 ± 6 25.8 ± 4.9 0.15
Nulliparity 136 128 0.138
Parity 1.34 ± 0.7 1.48 ± 0.9 0.11
Abortus 36 26 0.131
BMI at enrollment† 25.7 ± 3.7 25.2 ± 4.1 0.526
Conception by IVF 8 6 0.593
Smoker 11 5 0.128
Gestational age at diagnosis (weeks)† 34.08 ± 3.96 N/A N/A
Female to male ratio 95/104 (0.91) 108/103 (1.05) 0.104
Gestational age at delivery (weeks)† 35.8 ± 3.02 39.37 ± 1.16  < 0.001
Birth weight [g]† 2371 ± 790 2950 ± 768 < 0.001
Birth percentile 23.32 ± 28.22 40.44 ± 25.66 < 0.001
Cesarean delivery rate (%) 128 81 < 0.001
Hemoglobin 10.9 ± 1.8 11.5 ± 1.9 0.003
Leukocyte 11.1 ± 2.3 10.7 ± 2.3 0.105
Neutrophils [103/mm–3]† 7.3 ± 2 5.9 ± 1.5 < 0.001
Lymphocytes [103/mm–3]† 2.07 ± 0.63 2.19 ± 0.92 0.095
Platelets [103/mm–3]† 270.1 ± 59.8 229.9 ± 60.2 < 0.001
NLR† 3.8 ± 1.5 3.1 ± 1.3 < 0.001
PLR† 141.9 ± 50.8 118.5 ± 47.2 < 0.001
† Values are expressed as mean ± standard deviation or n (%) unless otherwise specified; BMI — body mass index; IVF — in-vitro fertilization; N/A — not available; NLR 
— neutrophil to lymphocyte ratio; PLR — platelet to lymphocyte ratio
Table 2. Significant predictors of preeclampsia in multivariate 
regression analysis
Markers Odds ratio 95% CI P value
Hemoglobin 0.95 0.87–1.21 0.242
Neutrophil 1.24 0.98–2.14) 0.096
Platelet 1.18 0.95–1.87 0.105
NLR 1.43 1.21–1.76 0.005
PLR 1.38 1.15–1.63 0.008
CI — confidence interval; NLR — neutrophil to lymphocyte ratio; PLR 
— platelet to lymphocyte ratio
gesting that elevated NLR and PLR are available markers 
for predicting vascular events which are associated with 
increased inflammation [15]. In a previous paper, high PLR 
and NLR were reported in non-dipper hypertensive pa-
tients, which is associated with end-organ damage and 
cardiovascular mortality [16]. As endothelial pathology and 
end-organ damage are common features of non-dipper 
hypertension and preeclampsia, PLR and NLR were also 
found to be elevated in our study. Contrary to our study, 
Kurt et al., reported that NLR was not significantly different 
between preeclampsia and control groups, although the 
neutrophil count was significantly higher in the group with 
preeclampsia [9]. However, recently NLR has been reported 
to be significantly higher in preeclamptic patients in two 
publications supporting our results [17, 18]. The ROC analysis 
of our study showed the NLR value of 3.08 or higher, with 
the sensitivity of 74.6%, specificity of 70.1% and a PLR value 
of 126.8 or higher, with the sensitivity of 71.8%, specificity of 
72.4% to predict preeclampsia. Therefore, the use of these 
markers in clinical practice seems adequate. 
Our study is not without limitations, e.g. the effect of 
unidentified confounding factors due to retrospective de-
sign. We are of the opinion that some missing data such as 
autoimmune diseases, antiphospholipid syndrome, and 
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short interpregnancy interval could also confound the ef-
fects. However, this potential selection bias was likely to be 
reduced by excluding some of the strongest risk factors in-
cluding age, parity, body mass index, and systemic illnesses.
CONCLUSIONS
Our data revealed that both, NLR and PLR in the first 
trimester of pregnancy could be used for the early diagnosis 
of preeclampsia. NLR and PLR are inexpensive, rapid and 
easily applicable tests for determining the pregnancies at 
risk for preeclampsia. Our study can provide useful basic 
information for clinical practice in detecting asymptomatic 
women at increased risk for preeclampsia. Thus, it is also 
suggested that pregnant women with high NLR and PLR 
during the first trimester of pregnancy should be monitored 
closely for signs of preeclampsia such as hypertension and 
proteinuria.
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Figure 1. Receiver operating characteristic curves for neutrophil to lymphocyte ratio (NLR) (A) and platelet to lymphocyte ratio (PLR) (B) used 
to make the clinical decision regarding preeclampsia. The areas under the receiver operating characteristic curve (ROC) were 0.716 and 0.705, 
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